Mitochondrial and genomic ancestry are associated with etiology of heart failure in Brazilian patients

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorCARDENA, M. M. S. G.
dc.contributor.authorRIBEIRO-DOS-SANTOS, A. K.
dc.contributor.authorSANTOS, S. E. B.
dc.contributor.authorMANSUR, A. J.
dc.contributor.authorBERNARDEZ-PEREIRA, S.
dc.contributor.authorSANTOS, P. C. J. L.
dc.contributor.authorPEREIRA, A. C.
dc.contributor.authorFRIDMAN, C.
dc.date.accessioned2016-07-04T13:56:06Z
dc.date.available2016-07-04T13:56:06Z
dc.date.issued2016
dc.description.abstractThere is a high prevalence of heart failure (HF) in the general population, but it is more common in black people. We evaluated the association between genomic ancestry and mitochondrial haplogroups (mt-haplogroups) with HF etiology in 503 Brazilian patients. We elicited Mt-haplogroups by analyzing the control region of mitochondrial DNA, and genomic ancestry, by using 48 autosomal insertiondeletion ancestry informative markers. Hypertensive (28.6%, n = 144) and ischemic (28.4%, n = 143) etiologies of HF were the most prevalent herein. Our results showed that 233 individuals (46.3%) presented African mitochondrial (mt)-haplogroups, and the major contribution in the genomic ancestry analysis was the European ancestry (57.5% (+/- 22.1%)). African mt-haplogroups were positively associated with a diagnosis of hypertensive cardiomyopathy (odds ratio, OR 1.55, confidence interval, CI 95% 1.04-2.44, P = 0.04) when compared with European mt-haplogroups. Regarding the genomic ancestry, the African ancestry variant had higher risks (OR 7.84, 95% CI 2.81-21.91, P < 0.001), whereas the European ancestry variant had lower risks (OR 0.14, 95% CI 0.04-5.00, P < 0.001) for developing the hypertensive etiology. In addition, European ancestry showed an OR of 4.05 (CI 95% 1.53-10.74, P = 0.005), whereas African ancestry showed an OR of 0.17 (CI 95% 0.06-0.48, P = 0.001) for developing ischemic etiology. In conclusion, this study supports the importance of using ancestry informative markers and mitochondrial DNA to study the genetics of complex diseases in admixed populations to improve the management, treatment and prevention of these illnesses. Therefore, the ancestry informative markers and mt-haplogroups could provide new biomarkers to be associated with HF etiologies and be used as a premise for more specific management.
dc.description.indexMEDLINE
dc.description.sponsorshipFAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)
dc.description.sponsorshipCAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)
dc.description.sponsorshipHC-LIM/FMUSP
dc.identifier.citationJOURNAL OF HUMAN HYPERTENSION, v.30, n.2, p.120-123, 2016
dc.identifier.doi10.1038/jhh.2015.39
dc.identifier.eissn1476-5527
dc.identifier.issn0950-9240
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/13937
dc.language.isoeng
dc.publisherNATURE PUBLISHING GROUP
dc.relation.ispartofJournal of Human Hypertension
dc.rightsrestrictedAccess
dc.rights.holderCopyright NATURE PUBLISHING GROUP
dc.subject.otherracial-differences
dc.subject.othermyocardial-infarction
dc.subject.otherwide association
dc.subject.otherblack-americans
dc.subject.otherblood-pressure
dc.subject.otherhypertension
dc.subject.otherrisk
dc.subject.otheradmixture
dc.subject.otherafrican
dc.subject.otheratherosclerosis
dc.subject.wosPeripheral Vascular Disease
dc.titleMitochondrial and genomic ancestry are associated with etiology of heart failure in Brazilian patients
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.author.externalRIBEIRO-DOS-SANTOS, A. K.:Fed Univ Para, Lab Human Genet & Med, BR-66059 Belem, Para, Brazil
hcfmusp.author.externalSANTOS, S. E. B.:Fed Univ Para, Lab Human Genet & Med, BR-66059 Belem, Para, Brazil
hcfmusp.citation.scopus6
hcfmusp.contributor.author-fmusphcMARI MAKI SIRIA GODOY CARDENA
hcfmusp.contributor.author-fmusphcALFREDO JOSE MANSUR
hcfmusp.contributor.author-fmusphcSABRINA BERNARDEZ PEREIRA
hcfmusp.contributor.author-fmusphcPAULO CALEB JUNIOR DE LIMA SANTOS
hcfmusp.contributor.author-fmusphcALEXANDRE DA COSTA PEREIRA
hcfmusp.contributor.author-fmusphcCINTIA FRIDMAN RAVE
hcfmusp.description.beginpage120
hcfmusp.description.endpage123
hcfmusp.description.issue2
hcfmusp.description.volume30
hcfmusp.origemWOS
hcfmusp.origem.pubmed25947276
hcfmusp.origem.scopus2-s2.0-84953356946
hcfmusp.origem.wosWOS:000370448900008
hcfmusp.publisher.cityLONDON
hcfmusp.publisher.countryENGLAND
hcfmusp.relation.referenceBrown CD, 2000, OBES RES, V8, P605, DOI 10.1038/oby.2000.79
hcfmusp.relation.referenceRathore SS, 2006, AM HEART J, V152, P371, DOI 10.1016/j.ahj.2005.12.002
hcfmusp.relation.referenceFreedman BI, 2013, AM J KIDNEY DIS, V62, P1165, DOI 10.1053/j.ajkd.2013.05.024
hcfmusp.relation.referenceMartinez-Redondo D, 2010, MITOCHONDRION, V10, P102, DOI 10.1016/j.mito.2009.11.005
hcfmusp.relation.referenceEast MA, 2004, AM HEART J, V148, P151, DOI 10.1016/j.ahj.2004.01.017
hcfmusp.relation.referenceBibbins-Domingo K, 2009, NEW ENGL J MED, V360, P1179, DOI 10.1056/NEJMoa0807265
hcfmusp.relation.referenceShahabi A, 2013, EPIDEMIOLOGY, V24, P285, DOI 10.1097/EDE.0b013e31828174cb
hcfmusp.relation.referenceZhu XF, 2005, NAT GENET, V37, P177, DOI 10.1038/ng1510
hcfmusp.relation.referenceKosoy R, 2012, J HUM HYPERTENS, V26, P365, DOI 10.1038/jhh.2011.52
hcfmusp.relation.referenceLai CQ, 2009, HUM GENET, V125, P199, DOI 10.1007/s00439-008-0612-7
hcfmusp.relation.referenceDeloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480
hcfmusp.relation.referenceAggarwal A, 2012, ASAIO J, V58, P499, DOI 10.1097/MAT.0b013e318268ea80
hcfmusp.relation.referenceKessler T, 2014, INTERNIST, V55, P141, DOI 10.1007/s00108-013-3304-x
hcfmusp.relation.referenceHuffman MD, 2013, J AM COLL CARDIOL, V61, P1510, DOI 10.1016/j.jacc.2013.01.022
hcfmusp.relation.referenceGordon HS, 2010, AM J CARDIOL, V105, P694, DOI 10.1016/j.amjcard.2009.10.051
hcfmusp.relation.referenceChen J, 2013, J AM COLL CARDIOL, V61, P1078, DOI 10.1016/j.jacc.2012.11.057
hcfmusp.relation.referenceMUNE T, 1995, NAT GENET, V10, P394, DOI 10.1038/ng0895-394
hcfmusp.relation.referenceErdmann J, 2010, DTSCH ARZTEBL INT, V107, P694, DOI 10.3238/arztebl.2010.0694
hcfmusp.relation.referenceRea IM, 2013, AGE, V35, P1445, DOI 10.1007/s11357-012-9444-4
hcfmusp.relation.referenceMarcuello A, 2009, MITOCHONDRION, V9, P326, DOI 10.1016/j.mito.2009.04.007
hcfmusp.relation.referenceMCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601
hcfmusp.relation.referenceMarroni AS, 2005, NITRIC OXIDE-BIOL CH, V12, P177, DOI 10.1016/j.niox.2005.02.002
hcfmusp.relation.referenceWatson B, 2001, AM J KIDNEY DIS, V38, P529, DOI 10.1053/ajkd.2001.26848
hcfmusp.relation.referenceBudoff MJ, 2006, ATHEROSCLEROSIS, V187, P343, DOI 10.1016/j.atherosclerosis.2005.09.013
hcfmusp.relation.referenceFranceschini N, 2013, AM J HUM GENET, V93, P545, DOI 10.1016/j.ajhg.2013.07.010
hcfmusp.relation.referenceRichardson P, 1996, CIRCULATION, V93, P841
hcfmusp.relation.referenceBahrarni H, 2008, ARCH INTERN MED, V168, P2138, DOI 10.1001/archinte.168.19.2138
hcfmusp.relation.referenceBernardez-Pereira S, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-90
hcfmusp.relation.referenceBocchi EA, 2012, ARQ BRAS CARDIOL, V98, P1, DOI 10.1590/S0066-782X2012000700001
hcfmusp.relation.referenceCardena MMSG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062005
hcfmusp.relation.referenceFranceschini N, 2014, AM J PHYSIOL-RENAL, V306, pF1, DOI 10.1152/ajprenal.00334.2013
hcfmusp.relation.referenceGiolo SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037392
hcfmusp.relation.referenceGonzález Jaime, 2014, World J Cardiol, V6, P353, DOI 10.4330/wjc.v6.i6.353
hcfmusp.relation.referenceHunt Sharon Ann, 2005, J Am Coll Cardiol, V46, pe1, DOI 10.1016/j.jacc.2005.08.022
hcfmusp.relation.referenceLeite TKM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027162
hcfmusp.relation.referencePena Sérgio D J, 2005, Hist Cienc Saude Manguinhos, V12, P321, DOI 10.1590/S0104-59702005000200006
hcfmusp.relation.referenceThe Coronary Artery Disease (C4d) Genetics Consortium, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782
hcfmusp.relation.referenceVara D, 2014, CURR MOL MED, V14, P1103
hcfmusp.relation.referenceWojczynski MK, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-75
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublication819a68df-2d6a-4494-b50d-7a4c1aadbbeb
relation.isAuthorOfPublicationc3913f3d-ab34-4de5-ab2a-0a9de5106e00
relation.isAuthorOfPublicationc3d8789b-57ee-44fd-92d5-41ba73e18e14
relation.isAuthorOfPublicationc78fbf09-2a91-499f-862e-74830b3b5fab
relation.isAuthorOfPublication415ce7ca-65c1-4699-b6f4-19dae8b03849
relation.isAuthorOfPublicationbb232bec-8a83-4598-883d-bfaf798a3f20
relation.isAuthorOfPublication.latestForDiscovery819a68df-2d6a-4494-b50d-7a4c1aadbbeb
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_CARDENA_Mitochondrial_and_genomic_ancestry_are_associated_with_etiology_2016.PDF
Tamanho:
194.59 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)